An individual drug-therapy and genetic testing report of temporal bone verrucous carcinoma

0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Objective: To investigate the pathology and pathogenesis of and treatment methods for temporal bone verrucous carcinoma. Materials and methods: A single-patient report of verrucous carcinoma on the left external auditory canal is presented and analyzed along with all cases of temporal bone verrucous carcinoma that have been documented in the English literature. Results: Most of the patients with verrucous carcinoma of the temporal bone have histories of surgery, trauma, or infection, and verrucous carcinomas are sensitive to antimicrotubule chemotherapeutic medicines. Adjuvant radiation therapy is not effective, but surgical treatment might be relatively more effective. Conclusion: Temporal bone verrucous carcinoma has a poor prognosis; therefore, the preferred treatment is surgical resection facilitated with antimicrotubule chemotherapeutic treatment. Adjuvant radiation therapy is not a preferred treatment for temporal bone verrucous carcinoma.

Cite

CITATION STYLE

APA

Tan, H., Liu, Y., Zhu, G., Pi, L., Huang, D., & Zhang, X. (2014). An individual drug-therapy and genetic testing report of temporal bone verrucous carcinoma. OncoTargets and Therapy, 7, 1535–1540. https://doi.org/10.2147/OTT.S66145

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free